[Utilization of trimethylammonium-compounds by Acinetobacter calcoaceticus (author's transl)]
- PMID: 849100
- DOI: 10.1007/BF00429336
[Utilization of trimethylammonium-compounds by Acinetobacter calcoaceticus (author's transl)]
Abstract
The utilization of carnitine and carnitine derivatives (O-acylcarnitines, carnitine carboxylderivatives) and structure-related trimethylammonium-compounds (betaines and nitrogen-bases) by Acinetobacter calcoaceticus was studied by means of the control of growth and the quantitative detection of metabolites. The strain grew only on L-carnitine, L-O-acylcarnitines, and gamma-butyrobetaine as the sole carbon sources. The utilization of these compounds and the growth correlated with the cleavage of the C-N bond and thereby with the formation of trimethylamin. D-Carnitine was metabolized, if an additional carbon source, like L-carnitine, was present in the incubation mixture, or if the bacteria were preincubated with L- or DL-carnitine, but no growth was observed on D-carnitine as the sole carbon source. The bacteria oxidized choline to glycinebetaine in the presence of additional carbon sources, glycinebetaine itself was not assimilated. With regard to the catabolism of quaternary nitrogen compounds Acinetobacter calcoaceticus shows a different pathway in comparison with other bacterial species metabolizing carnitine.
Similar articles
-
[Interrelationships between carnitine metabolism and fatty acid assimilation in Pseudomonas putida (author's transl)].Arch Microbiol. 1978 Feb;116(2):213-20. doi: 10.1007/BF00406039. Arch Microbiol. 1978. PMID: 565193 German.
-
Bacterial carnitine metabolism.FEMS Microbiol Lett. 1997 Feb 1;147(1):1-9. doi: 10.1111/j.1574-6968.1997.tb10212.x. FEMS Microbiol Lett. 1997. PMID: 9037756 Review.
-
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.Life Sci. 2014 Nov 11;117(2):84-92. doi: 10.1016/j.lfs.2014.09.028. Epub 2014 Oct 7. Life Sci. 2014. PMID: 25301199
-
CaiT of Escherichia coli, a new transporter catalyzing L-carnitine/gamma -butyrobetaine exchange.J Biol Chem. 2002 Oct 18;277(42):39251-8. doi: 10.1074/jbc.M206319200. Epub 2002 Aug 5. J Biol Chem. 2002. PMID: 12163501
-
Carnitine metabolism and its regulation in microorganisms and mammals.Annu Rev Nutr. 1998;18:39-61. doi: 10.1146/annurev.nutr.18.1.39. Annu Rev Nutr. 1998. PMID: 9706218 Review.
Cited by
-
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.J Clin Invest. 2019 Jan 2;129(1):373-387. doi: 10.1172/JCI94601. Epub 2018 Dec 10. J Clin Invest. 2019. PMID: 30530985 Free PMC article. Clinical Trial.
-
Carnitine in bacterial physiology and metabolism.Microbiology (Reading). 2015 Jun;161(6):1161-74. doi: 10.1099/mic.0.000080. Epub 2015 Mar 18. Microbiology (Reading). 2015. PMID: 25787873 Free PMC article. Review.
-
Crotonobetaine reductase from Escherichia coli--a new inducible enzyme of anaerobic metabolization of L(-)-carnitine.Antonie Van Leeuwenhoek. 1994;65(1):63-9. doi: 10.1007/BF00878280. Antonie Van Leeuwenhoek. 1994. PMID: 8060125
-
Metabolism of D: (+)-carnitine by Escherichia coli.Appl Microbiol Biotechnol. 1991 Jun;35(3):393-395. doi: 10.1007/BF00172731. Appl Microbiol Biotechnol. 1991. PMID: 22622940
-
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.Cell Metab. 2014 Nov 4;20(5):799-812. doi: 10.1016/j.cmet.2014.10.006. Epub 2014 Nov 4. Cell Metab. 2014. PMID: 25440057 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources